다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Quince Therapeutics Inc (QNCX)
Quince Therapeutics Inc (QNCX) 뉴스

QNCX

Quince Therapeutics (QNCX)

Quince Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:QNCX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/13	20:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/05/13	20:00	Business Wire	Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc
2024/05/07	05:05	Business Wire	Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference	NASDAQ:QNCX	Quince Therapeutics Inc
2024/04/01	20:00	Business Wire	Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results	NASDAQ:QNCX	Quince Therapeutics Inc
2024/02/22	21:00	Business Wire	Quince Therapeutics Launches Scientific Advisory Board	NASDAQ:QNCX	Quince Therapeutics Inc
2024/02/16	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2024/02/15	21:00	Business Wire	Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors	NASDAQ:QNCX	Quince Therapeutics Inc
2024/02/08	06:05	Business Wire	Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:QNCX	Quince Therapeutics Inc
2024/02/03	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2024/01/06	06:01	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:QNCX	Quince Therapeutics Inc
2024/01/05	06:05	Business Wire	Quince Therapeutics to Participate at Investor Events in January 2024	NASDAQ:QNCX	Quince Therapeutics Inc
2024/01/04	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/12/23	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/12/15	08:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/12/09	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/12/08	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/12/02	03:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/10/27	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/10/25	08:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/10/25	08:34	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/10/24	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/10/23	20:00	Business Wire	Quince Therapeutics Completes Acquisition of EryDel S.p.A.	NASDAQ:QNCX	Quince Therapeutics Inc
2023/09/29	05:53	Dow Jones News	Quince Therapeutics to Advance Study of EryDex as FDA Lifts Application Hold	NASDAQ:QNCX	Quince Therapeutics Inc
2023/09/29	05:05	Business Wire	U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia	NASDAQ:QNCX	Quince Therapeutics Inc
2023/09/06	20:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/09/06	20:00	Business Wire	Quince Therapeutics Appoints Dr. Charles S. Ryan as President	NASDAQ:QNCX	Quince Therapeutics Inc
2023/09/01	07:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/08/18	07:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QNCX	Quince Therapeutics Inc
2023/08/11	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QNCX	Quince Therapeutics Inc
2023/08/11	05:05	Business Wire	Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023	NASDAQ:QNCX	Quince Therapeutics Inc

검색 관련기사 보기:NASDAQ:QNCX

1 2 3 4 5 6 7 8 9 10 다음 >>

Innovative Health Care P...

NFTLAUNCH.network

사조씨푸드

Bank of Marin Bancorp

Neo Performance Materials (PK)

Obligaciones Tf 1% Ot50 ...

Region Wallonne 1.438% u...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관